Celiac disease mechanism and therapies (Homo sapiens)
From WikiPathways
Description
No description
Quality Tags
Ontology Terms
Bibliography
- Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y; ''Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.''; MAbs, 2017 PubMed Europe PMC Scholia
- Dieckman T, Koning F, Bouma G; ''Celiac disease: New therapies on the horizon.''; Curr Opin Pharmacol, 2022 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
AGY | Metabolite | ||
CALY-002 | Metabolite | ||
CD4 | GeneProduct | ||
DHODH | GeneProduct | ||
Deaminated
gluten peptide | Metabolite | ||
EGFR | GeneProduct | ||
GSK3915393 | Metabolite | ||
GZMB | GeneProduct | ||
Gluten | Metabolite | ||
Gluten peptide | Metabolite | ||
HLA-DQ2 | GeneProduct | ||
HLA-DQ8 | GeneProduct | ||
IFNG | GeneProduct | ||
IL15 | GeneProduct | ||
IL2 | GeneProduct | ||
IL21 | GeneProduct | ||
ITGA4 | GeneProduct | ||
ITGB7 | GeneProduct | ||
Inflammation | |||
KAN-101 | Metabolite | ||
Larazotide | Metabolite | ||
Latiglutenase | Metabolite | ||
Loss of tolerance | |||
PAR2 | GeneProduct | ||
PRV-015 | Metabolite | ||
PTG-100 | Metabolite | ||
Pyrimidine synthesis | Pathway | ||
TAK-062 | Metabolite | ||
TAK-101 | Metabolite | ||
TG2 | GeneProduct | ||
TNFA | GeneProduct | ||
TRA | GeneProduct | ||
TRB | GeneProduct | ||
Teriflunomide | Metabolite | ||
Tolerase G | Metabolite | ||
ZED1227 | Metabolite |
Annotated Interactions
No annotated interactions